Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking. Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R. Sci Rep. 2022 Aug 30;12(1):14754.

30 Aug 2022
0

Prediction of the structural interface between fibroblast growth factor23 and Burosumab using alanine scanning and molecular docking.

Kanhasut K, Tharakaraman K, Ruchirawat M, Satayavivad J, Fuangthong M, Sasisekharan R.

Sci Rep. 2022 Aug 30;12(1):14754.

Tags

Share this

Related Posts

Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3

Recent Posts